Accord Healthcare acquired NJ based Essential Pharmaceuticals, leading Organ Preservation Solution maker – Katalyst HLS

Accord Healthcare announced the acquisition of Ewing, New Jersey-based Essential Pharmaceuticals. Under the terms of the agreement, along with the Essential company, Accord has acquired the rights to sell Custodiol® HTK Solution ( in the United States and Canada. Custodiol® HTK Solution is a leading organ preservation solution indicated for perfusion and flushing of donor kidneys, liver, pancreas and heart prior to and after removal from donor.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s